Latest Breaking News On - Zhong lun law firm - Page 3 : comparemela.com
YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the appointment of six new members to its Board of Directors (the "Board"), effective February 13, 2024. The six new directors are: Dr. Yuntao Cui; Dr. Jin Wang; Mr. Henry
United-statesBeijingChinaShanxiFujianManhattanNew-yorkJin-wangZhejiangZhong-lunJiangxiCalifornia